Sandoz Fails To Obtain US Remodulin Injunction
But United Therapeutics And Smiths Cannot Dismiss Suit
Sandoz has failed to obtain an injunction as part of US litigation against United Therapeutics, which the generics firm says has taken anti-competitive action to block patient access to its generic version of Remodulin.
